Clinical applications of next‐generation sequencing‐based <scp>ctDNA</scp> analyses in breast cancer: defining treatment targets and dynamic changes during disease progression
Eva Valentina Klocker(Medical University of Graz), Michael Gnant(Austrian Breast & Colorectal Cancer Study Group), Samantha O. Hasenleithner(Medical University of Graz), Andreas Petzer(Ordensklinikum Linz Barmherzige Schwestern), Simon Peter Gampenrieder(University of Salzburg), Rupert Bartsch(Universitätszahnklinik Wien), Daniel Egle(Innsbruck Medical University), Ellen Heitzer(Medical University of Graz), Gabriel Rinnerthaler(Medical University of Graz), Marija Balić(University of Pittsburgh), Katja Schmitz(Goethe University Frankfurt), Michael Hubalek(Innsbruck Medical University), Christian F. Singer(Comprehensive Cancer Center Vienna), Sonja Heibl(Klinikum Wels-Grieskirchen), Zsuzsanna Bagó-Horváth(Comprehensive Cancer Center Vienna)
Cited by 15
Related Papers
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Breast cancer
|The Lancet|2016|2.3k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
|Annals of Oncology|2021|1.4k